Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
Pramod K. Mistry,Manisha Balwani,Hagit N. Baris,Hadhami Ben Turkia,T. Andrew Burrow,Joel Charrow,Gerald F. Cox,Sumita Danda,Marta Dragosky,Guillermo Drelichman,Amal El-Beshlawy,Cristina Fraga,Selena Freisens,Sebastiaan J.M. Gaemers,Evgueniy Hadjiev,Priya S. Kishnani,Elena Lukina,Pierre Maison-Blanche,Ana Maria Martins,Gregory M. Pastores,Milan Petakov,M. Judith Peterschmitt,Hanna Rosenbaum,Barry E. Rosenbloom,Lisa H. Underhill,Timothy M. Cox Blood Cells, Molecules, and Diseases(2018)
AI 理解论文
溯源树
样例